Exclusions from the Section 301 tariffs on imports from China for 81 medical care products needed to address the COVID-19 pandemic have been extended from Nov. 30 through Feb. 28, 2023. These exclusions are available for any product that meets the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request.
The Office of the U.S. Trade Representative states that it may consider further extensions and/or additional modifications in the future.
In the meantime, USTR is accepting comments through Jan. 17 as part of a review of all Section 301 tariffs on imports from China. ST&R can assist in preparing and submitting comments to USTR; for more information, please contact Ned Steiner at (202) 730-4970 or via email.
In addition, efforts to ameliorate the impact of these tariffs are continuing.
- ST&R is advocating for the renewal of all previously approved exclusions and the creation of a process allowing for new exclusion requests (for more information, please contact strdc@strtrade.com).
- There are a number of proven and legitimate ways to effectively avoid the tariffs or limit their impact (click here for more information).
- Importers of List 3 and 4A goods from China can still preserve their rights to possible refunds of tariffs paid on such goods by joining an ongoing court case (for more information, or assistance filing a claim, please contact us at 301Litigation@strtrade.com).
Copyright © 2025 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.